Foster Dykema Cabot & Partners, LLC Edwards Lifesciences Corp Call Options Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EW
# of Institutions
1,338Shares Held
470MCall Options Held
2.94MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.16 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.39 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.73 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.35 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.13 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $41.1B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...